谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract CT105: Preliminary Results from the Phase I Part of a First-in-human Phase I/II Study of HH2853, an EZH1/2 Inhibitor, in Patients with Relapsed/refractory Non-Hodgkin Lymphomas or Advanced Solid Tumors

Zhengfu Fan,Jin Wang,Meiyu Fang,Johnston Patrick,Tun Han,David Sommerhalder,Jifang Gong,Jilong Yang,Yun Yang,Javier Munoz,Yuqin Song,Zhiming Li,Xian'an Li, Qiuying Ma, Jinming Han,Lin Shen,Jun Zhu

Cancer Research（2023）

引用 0|浏览37
关键词
Intratumor Heterogeneity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要